Related Experiment Video
Updated: Mar 17, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
High cut-off dialysis in chronic haemodialysis patients reduces serum procalcific activity
Daniel Zickler1, Kevin Willy1, Matthias Girndt2
1Department of Nephrology and Internal Intensive Care Medicine, Charité-Universitaetsmedizin Berlin, Campus Virchow Clinic, Berlin, Germany.
Insights
High cut-off (HCO) dialysis membranes reduce vascular calcification in chronic dialysis patients. This study found HCO membranes lowered vascular cell adhesion molecule 1 (VCAM-1) levels, a key factor in calcification, suggesting improved treatment outcomes.
Area of Science:
- Nephrology
- Vascular Biology
- Biomedical Engineering
Background:
- Chronic dialysis patients exhibit enhanced vascular calcification, potentially due to inadequate removal of uremic toxins by conventional membranes.
- Intermediate molecular weight toxins, including interleukins, may contribute to vascular calcification in dialysis patients.
Purpose of the Study:
- To assess the impact of high cut-off (HCO) membranes on in vitro vascular calcification in chronic dialysis patients.
- To investigate the role of specific mediators, such as VCAM-1, in dialysis-induced vascular calcification.
Main Methods:
- A randomized crossover trial (PERCI trial) involving 43 chronic dialysis patients using conventional high-flux and HCO filters.
- Incubation of calcifying human coronary vascular smooth muscle cells (VSMCs) with patient serum samples post-dialysis.
- Assessment of calcification using alkaline phosphatase (ALP) and alizarin red staining; measurement of serum mediator levels (sTNFR1, sTNFR2, VCAM-1, sIL2R).
Main Results:
- HCO dialysis significantly reduced serum levels of sTNFR1, sTNFR2, VCAM-1, and sIL2R compared to high-flux dialysis.
- VSMCs incubated with serum from HCO dialysis showed a 26% reduction in ALP and a 43% reduction in alizarin staining compared to high-flux serum.
- VCAM-1 demonstrated a dose-dependent enhancement of VSMC calcification in vitro, while sIL2R, sTNFR1, and sTNFR2 had no significant effect.
Conclusions:
- High cut-off (HCO) dialysis membranes effectively reduce the procalcific effects of serum on VSMCs in vitro.
- Lowered VCAM-1 levels in HCO serum may contribute to the observed reduction in vascular calcification.
- Further research into highly permeable filters like HCO membranes is warranted for chronic dialysis patients to mitigate vascular calcification.
Background:
Vascular calcification is enhanced in chronic dialysis patients, possibly due to the insufficient removal of various intermediate molecular weight uraemic toxins such as interleukins with conventional membranes. In this study, we assessed the modulation of in vitro vascular calcification with the use of high cut-off (HCO) membranes in chronic dialysis patients.
Methods:
In a PERCI trial, 43 chronic dialysis patients were treated with conventional high-flux and HCO filters for 3 weeks in a randomized order following a 2-period crossover design. After each phase, serum predialysis samples were drawn. Calcifying human coronary vascular smooth muscle cells (VSMCs) were incubated with the patient's serum samples. Calcification was assessed with alkaline phosphatase (ALP) and alizarin red staining. In the clinical trial, HCO dialysis reduced the serum levels of the soluble tumour necrosis factor receptor (sTNFR) 1 and 2, vascular cell adhesion molecule 1 (VCAM-1) and soluble interleukin-2 receptor (sIL2R). We therefore investigated the in vitro effects of these mediators on vascular calcification.
Results:
VSMCs incubated with HCO dialysis serum showed a 26% reduction of ALP with HCO serum compared with high-flux serum. Alizarin was 43% lower after incubation with the HCO serum compared with the high-flux serum. While sIL2R and sTNFR 1 and 2 showed no effects on VSMC calcification, VCAM-1 caused a dose-dependent enhancement of calcification.
Conclusions:
The use of HCO dialysis membranes in chronic dialysis patients reduces the procalcific effects of serum on VSMC in vitro. The mechanisms of the strong effect of HCO on in vitro calcification are not completely understood. One factor may be lower levels of VCAM-1 in HCO serum samples, since VCAM-1 was able to induce vascular calcification in our experiments. Neither sTNFR 1, sTNFR 2 nor sIL2R enhance vascular calcification in vitro. Regardless of the mechanisms, our results encourage further studies of highly permeable filters in chronic dialysis patients.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis II: Procedure and Complications
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Hemodialysis III: Nursing Management
Acute Kidney Injury V: Interprofessional Care

